{"gene":"NOL3","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1998,"finding":"NOL3/ARC was identified as a novel apoptosis inhibitor containing an N-terminal CARD domain fused to a C-terminal proline/glutamic acid-rich region, expressed predominantly in skeletal muscle and cardiac tissue. Immunoprecipitation showed ARC interacts selectively with caspase-2, caspase-8, and C. elegans CED-3, but not caspase-1, -3, or -9. ARC inhibited caspase-8 enzymatic activity and blocked apoptosis induced by FADD, TRADD, and death receptors CD95/Fas, TNF-R1, and TRAMP/DR3.","method":"Immunoprecipitation, caspase activity assays, overexpression in 293T cells, death receptor stimulation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — original discovery paper with multiple orthogonal methods (Co-IP, enzymatic assay, functional rescue), highly cited foundational study","pmids":["9560245"],"is_preprint":false},{"year":1999,"finding":"Alternative splicing of the NOL3/NOP gene produces two isoforms with different C-terminal ends and distinct subcellular localizations: Nop30 (nuclear/nucleolar) and a cytosolic isoform with a proline/glutamic acid-rich C-terminus. Nop30 multimerizes and binds the RS domain of splicing factor SRp30c but not other splicing factors tested. Overexpression of Nop30 alters alternative exon usage in preprotachykinin and SRp20 reporter genes.","method":"Yeast two-hybrid screen, in vitro protein interaction assays, co-immunoprecipitation, overexpression reporter assays, immunofluorescence localization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple methods (Y2H, Co-IP, functional reporter) in single study; describes NOL3 isoform biology","pmids":["10196175"],"is_preprint":false},{"year":2002,"finding":"ARC function is regulated by protein kinase CK2, which phosphorylates ARC at threonine 149. This phosphorylation targets ARC to mitochondria. ARC can only bind caspase-8 when localized to mitochondria, not in the cytoplasm, establishing phosphorylation-dependent subcellular localization as a prerequisite for caspase inhibition.","method":"In vitro kinase assay, site-directed mutagenesis, subcellular fractionation, co-immunoprecipitation, overexpression","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay with mutagenesis plus localization and interaction studies, replicated across conditions","pmids":["12191471"],"is_preprint":false},{"year":2003,"finding":"ARC expression is reduced in the CA1 hippocampal region following transient global ischemia, coinciding with TUNEL-positive cell death. Forced expression of ARC in hippocampal neurons or B103 neuronal cells significantly reduced hypoxia-induced cell death, with the C-terminal P/E-rich region being effective in attenuating hypoxic insults.","method":"Western blotting, immunohistochemistry, TUNEL assay, forced expression in primary neuronal cultures and neuronal cell lines","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2-3 — loss-of-function correlative plus gain-of-function in neurons; domain mapping with C-terminal region","pmids":["12753927"],"is_preprint":false},{"year":2003,"finding":"ARC inhibits cardiomyocyte apoptosis in part by reducing K+ efflux through voltage-gated K+ (Kv) channels. Overexpression of ARC in H9c2 cells significantly decreased Kv currents, and suppressed the staurosporine-induced increase in Kv currents and subsequent apoptosis.","method":"Whole-cell patch clamp electrophysiology, overexpression in H9c2 cells, staurosporine-induced apoptosis assay","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 — direct electrophysiology with overexpression; single lab, single cell line","pmids":["12734105"],"is_preprint":false},{"year":2004,"finding":"ARC inhibits both extrinsic and intrinsic apoptosis pathways through nonhomotypic death-fold interactions. ARC's CARD domain engages heterotypic interactions with the death domains (DDs) of Fas and FADD, blocking Fas-FADD binding and DISC assembly. ARC also binds Bax via its CARD domain interacting with the Bax C-terminus, inhibiting Bax activation and mitochondrial translocation. Knockdown of endogenous ARC facilitates DISC assembly and triggers spontaneous Bax activation.","method":"Co-immunoprecipitation, DISC assembly assays, Bax activation assays, siRNA knockdown, overexpression","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (reciprocal Co-IP, DISC assay, Bax translocation, KD and OE), strong mechanistic resolution of nonhomotypic CARD interactions","pmids":["15383280"],"is_preprint":false},{"year":2004,"finding":"ARC co-immunoprecipitates with Bax and prevents Bax activation and cytochrome c release in hydrogen peroxide-treated H9c2 cells. The CARD domain of ARC (L31F mutant defective) is required for this interaction. Recombinant ARC protein abrogated Bax-induced cytochrome c release from isolated mitochondria. TAT-ARC transduction blocked cytochrome c release after ischemia/reperfusion.","method":"Co-immunoprecipitation, TAT-fusion protein transduction, isolated mitochondria assay, cytochrome c release assay, in vivo ischemia/reperfusion model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution with isolated mitochondria plus mutagenesis (L31F) plus in vivo validation","pmids":["15004034"],"is_preprint":false},{"year":2004,"finding":"ARC is a Ca2+-dependent regulator of caspase-8 and cell death. ARC protein binds Ca2+ through its C-terminal proline/glutamic acid-rich (P/E-rich) domain as shown by Ca2+ overlay and Stains-all assays. ARC expression reduces cytosolic Ca2+ transients and protects against Ca2+-mediated cytotoxicity. The protein-protein interaction between ARC and caspase-8 is decreased by elevated Ca2+ concentration in vitro and by thapsigargin treatment in vivo, linking calcium binding to regulation of caspase-8 inhibition.","method":"Ca2+ overlay assay, Stains-all staining, co-immunoprecipitation, siRNA knockdown, cell death assays with Ca2+ ionophores/thapsigargin","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple assays (Ca2+ binding, Co-IP, functional), single lab","pmids":["15509781"],"is_preprint":false},{"year":2005,"finding":"ARC is expressed at high levels in various non-myogenic and non-neurogenic human and rat cancer cell lines. In cancer cells, ARC localizes almost exclusively to the nucleus, unlike its cytoplasmic localization in non-cancer cells. Nuclear ARC in cancer cells does not co-localize with the Nop30 isoform (nucleolar).","method":"Immunofluorescence, subcellular fractionation, Western blotting in multiple cancer cell lines","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct localization experiments across multiple cell lines; functional implication of nuclear ARC distinct from cytoplasmic","pmids":["15848180"],"is_preprint":false},{"year":2006,"finding":"ARC-deficient mice develop normally but show accelerated cardiomyopathy under biomechanical stress (aortic banding) and markedly increased myocardial infarct sizes after ischemia/reperfusion. Increased apoptotic cardiomyocytes were observed in ARC-deficient mice under both stress conditions. ARC protein levels are markedly reduced in failing human hearts. ARC had no effect on hypertrophic cardiomyocyte growth responses.","method":"ARC knockout mouse generation, aortic banding model, ischemia/reperfusion model, cardiac function measurements, apoptosis assays, human heart tissue analysis","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 — clean KO mouse with defined cardiac phenotypes under two distinct stress conditions, plus human tissue validation","pmids":["16505176"],"is_preprint":false},{"year":2006,"finding":"ARC protein degradation is mediated by the ubiquitin-proteasomal pathway in response to death stimuli. Mutation of ARC ubiquitin acceptor residues stabilizes ARC protein, preserves its steady-state levels during apoptosis, and improves cytoprotection. Decreases in ARC protein levels during apoptosis are post-translational (not transcriptional) and constitute a trigger rather than a consequence of cell death.","method":"Pulse-chase experiments, ubiquitin acceptor site mutagenesis, proteasome inhibitor treatment, apoptosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis of ubiquitin sites plus pulse-chase plus functional rescue; mechanistic causality established","pmids":["17142452"],"is_preprint":false},{"year":2006,"finding":"MDM2 is a critical regulator of ARC protein levels in cardiomyocytes. Oxidative stress reduces ARC levels while upregulating MDM2. MDM2 directly accelerates ARC protein turnover via ubiquitination and proteasomal degradation, requiring a functioning MDM2 RING finger domain (C464A mutant cannot direct ARC degradation). MDM2 knockout fibroblasts show defective ARC degradation rescued by MDM2 reconstitution.","method":"MDM2 overexpression and knockdown, MDM2 C464A mutant, MDM2 knockout cells, ubiquitination assay, proteasome inhibitor rescue, Western blotting","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — identifies E3 ligase for ARC with mutagenesis, KO rescue, and in vivo cardiac model validation","pmids":["17142834"],"is_preprint":false},{"year":2007,"finding":"p53 transcriptionally represses ARC at both the mRNA and protein levels in response to reactive oxygen species and anoxia. p53-induced ARC repression is transcription-dependent. ARC can interact with proapoptotic proteins PUMA and Bad via its N-terminus, displacing their association with Bcl-2. p53-mediated ARC repression prevents ARC from counteracting PUMA/Bad proapoptotic activity.","method":"p53 knockdown (siRNA), quantitative RT-PCR, Western blotting, co-immunoprecipitation, domain mapping","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — siRNA knockdown plus Co-IP for binding partners; transcriptional mechanism inferred from mRNA/protein concordance","pmids":["17998337"],"is_preprint":false},{"year":2007,"finding":"ARC directly binds the p53 tetramerization domain in the nucleus, inhibiting p53 tetramerization. This exposes a nuclear export signal in p53 and triggers Crm1-dependent relocalization of p53 to the cytoplasm. Knockdown of endogenous ARC in breast cancer cells results in spontaneous p53 tetramerization, nuclear p53 accumulation, and activation of p53 target genes.","method":"Co-immunoprecipitation, nuclear/cytoplasmic fractionation, CRM1 inhibitor (leptomycin B), ARC siRNA knockdown, p53 target gene reporter assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (Co-IP, fractionation, pharmacological inhibition, KD) with clear mechanistic chain; single lab but strong evidence","pmids":["18087040"],"is_preprint":false},{"year":2008,"finding":"ARC is the only caspase-8 inhibiting regulator with consistently elevated expression across all stages of renal cell carcinomas. The ratio of ARC to caspase-8 mRNA is significantly increased during RCC carcinogenesis and tumor progression, suggesting ARC's inhibition of caspase-8 contributes to RCC chemoresistance.","method":"Quantitative RT-PCR in primary human RCC tissues and non-neoplastic renal tissue across tumor stages","journal":"Apoptosis : an international journal on programmed cell death","confidence":"Low","confidence_rationale":"Tier 4 — expression analysis only, no direct mechanistic experiment","pmids":["18516683"],"is_preprint":false},{"year":2010,"finding":"Ras induces ARC expression through effects on both transcription and protein stability. Overexpression of activated N-Ras or H-Ras increases ARC mRNA and protein. Ras activates the NOL3 promoter in a MEK/ERK-dependent manner. Ras also stabilizes ARC protein by suppressing its polyubiquitination and proteasomal degradation. ARC mediates Ras-induced cell survival and cell cycle progression.","method":"Activated Ras overexpression, N-Ras siRNA knockdown, promoter reporter assay, MEK inhibitor treatment, ubiquitination assay, transgenic mouse model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (promoter assay, KD, OE, MEK inhibitor, in vivo transgenic) in single study establishing full pathway","pmids":["20392691"],"is_preprint":false},{"year":2011,"finding":"ARC promotes breast carcinogenesis by driving primary tumor growth, invasion, and metastasis, and by conferring chemoresistance. In the PyMT transgenic model, deletion of the ARC-encoding gene nol3 decreased primary tumor burden and markedly reduced lung metastases. Ectopic ARC overexpression in metastatic breast cancer cells increased invasion in vitro and lung metastasis in vivo. RNAi-mediated knockdown of ARC in human MDA-MB-231-LM2 cells reduced tumor volume, local invasion, and lung metastases.","method":"ARC knockout in PyMT transgenic mice, ARC overexpression in metastatic cell line, RNAi knockdown in humanized orthotopic model, in vitro invasion assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function and gain-of-function in vivo models with defined metastatic phenotype; two independent model systems","pmids":["22037876"],"is_preprint":false},{"year":2012,"finding":"A mutation in NOL3 (identified by targeted sequencing and linkage to chromosome 16q21-22.1) cosegregates with familial cortical myoclonus in a 4-generation Canadian Mennonite family. This mutation was found to alter post-translational modification of NOL3 protein in vitro, suggesting altered NOL3 function underlies neuronal membrane hyperexcitability and myoclonus.","method":"SNP mapping, microsatellite linkage, targeted massively parallel sequencing, Sanger sequencing, in vitro post-translational modification assay","journal":"Annals of neurology","confidence":"Medium","confidence_rationale":"Tier 2-3 — genetic linkage plus in vitro functional assay of PTM alteration; mechanism partially characterized","pmids":["22926851"],"is_preprint":false},{"year":2014,"finding":"ARC blocks TNFα-induced regulated necrosis in addition to apoptosis. TNFα-induced necrosis was abrogated by wild-type ARC overexpression but not by a CARD-domain mutant. ARC knockdown exacerbated TNFα-induced necrosis rescued by wild-type but not CARD-defective ARC. The mechanism involves ARC interaction with TNF receptor 1 (TNFR1), interfering with RIP1 recruitment to TNFR1, a critical step in TNFα-induced necrosis.","method":"ARC overexpression and siRNA knockdown, CARD domain mutagenesis, co-immunoprecipitation with TNFR1, RIP1 recruitment assay, in vivo vaccinia virus infection model","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — multiple methods (OE, KD, CARD mutagenesis, Co-IP of TNFR1-RIP1, in vivo model) converge on novel anti-necrotic mechanism","pmids":["24440909"],"is_preprint":false},{"year":2015,"finding":"ARC deficiency in skeletal muscle leads to lower maximum tetanic force, fiber type shift toward type II fibers, reduced fiber cross-sectional area, increased DNA fragmentation, and elevated apoptosis-inducing factor (AIF) in cytosolic fractions. Mitochondria from ARC KO red muscle are more susceptible to calcium stress. These effects occur independent of caspase or calpain activation, indicating caspase-independent mitochondrial apoptotic signaling.","method":"ARC knockout mice, muscle contractility measurements, fiber typing, TUNEL assay, subcellular fractionation, AIF Western blot, isolated mitochondrial calcium stress assay","journal":"Apoptosis : an international journal on programmed cell death","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple functional and biochemical readouts; mitochondrial mechanism validated ex vivo","pmids":["25596718"],"is_preprint":false},{"year":2016,"finding":"Tat-fused NOL3 protein transduces into HT22 hippocampal cells and inhibits H2O2-induced reactive oxygen species production, DNA fragmentation, and mitochondrial membrane potential loss. Tat-NOL3 prevents neuronal cell death by regulating apoptotic signaling including Bax, Bcl-2, caspase-2, -3, -8, PARP, and p53. In a forebrain ischemia model, Tat-NOL3 transduced into brain tissue and protected CA1 hippocampal neurons by regulating microglial and astrocyte activation.","method":"TAT-fusion protein transduction, ROS measurement, mitochondrial membrane potential assay, Western blotting of apoptotic markers, in vivo ischemia model with immunohistochemistry","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — TAT-protein delivery with multiple downstream pathway readouts in vitro and in vivo; single lab","pmids":["27221790"],"is_preprint":false},{"year":2019,"finding":"ARC regulates leukemia-microenvironment interactions through an ARC/IL1β/Cox-2/PGE2/β-catenin/ARC circuit. AML-MSC cocultures increase Cox-2 expression in MSCs and PGE2 production in an ARC/IL1β-dependent manner. PGE2 induces β-catenin expression in AML cells, which in turn regulates ARC levels. β-catenin inhibition decreases ARC and sensitizes AML cells to chemotherapy. ARC-knockdown AML cells in mice show lower IL1β/PGE2 levels and increased chemosensitivity.","method":"AML-MSC co-culture, ARC knockdown, β-catenin inhibition, ELISA for IL1β and PGE2, xenograft mouse model with ARC-knockdown cells","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2-3 — circuit validated in co-culture and in vivo xenograft with multiple biochemical readouts; single lab","pmids":["30674535"],"is_preprint":false},{"year":2021,"finding":"NOL3/ARC inhibits both intrinsic (mitochondrial) and extrinsic (death receptor) apoptosis pathways, as well as necrosis, through its CARD domain. ARC interacts with Bax, Bcl-2, caspase-2, caspase-8, FADD, Fas, and TNFR1. ARC also modulates ER stress responses, oxidative stress, and Ca2+ homeostasis in cardiomyocytes. CK2-mediated phosphorylation at Thr149 governs ARC's mitochondrial localization and caspase inhibitory function.","method":"Review synthesizing co-immunoprecipitation, mutagenesis, knockout mouse data, and in vitro/in vivo functional studies from multiple prior publications","journal":"Apoptosis : an international journal on programmed cell death","confidence":"Medium","confidence_rationale":"Tier 3 — review article synthesizing established mechanistic findings; confidence based on underlying primary studies","pmids":["33604728"],"is_preprint":false}],"current_model":"NOL3/ARC is a CARD-containing anti-apoptotic protein predominantly expressed in terminally differentiated cells (cardiomyocytes, skeletal muscle, neurons) that inhibits both extrinsic and intrinsic apoptosis pathways and TNFα-induced necrosis through nonhomotypic CARD-domain interactions with Fas/FADD death domains, Bax, caspase-8, and TNFR1/RIP1; its activity is regulated by CK2-mediated phosphorylation at Thr149 (governing mitochondrial targeting and caspase-8 binding), MDM2/Ras-MEK/ERK-controlled ubiquitin-proteasomal degradation, calcium binding via its P/E-rich domain, and nuclear localization in cancer cells where it inactivates p53 by blocking tetramerization and triggering Crm1-dependent nuclear export."},"narrative":{"teleology":[{"year":1998,"claim":"Identification of ARC as a tissue-restricted, CARD-containing caspase inhibitor established that a dedicated anti-apoptotic protein exists in skeletal and cardiac muscle to block death-receptor signaling.","evidence":"Co-immunoprecipitation and caspase activity assays in 293T cells with death receptor stimulation","pmids":["9560245"],"confidence":"High","gaps":["Endogenous loss-of-function not yet tested","Mechanism of selective caspase recognition unknown","Intrinsic pathway role not addressed"]},{"year":1999,"claim":"Discovery of alternative splicing producing a nuclear/nucleolar Nop30 isoform that modulates pre-mRNA splicing revealed that NOL3 has functions beyond apoptosis inhibition.","evidence":"Yeast two-hybrid, Co-IP with splicing factor SRp30c, and alternative splicing reporter assays","pmids":["10196175"],"confidence":"Medium","gaps":["Physiological relevance of Nop30-mediated splicing regulation not established in vivo","Relationship between nucleolar and cytoplasmic isoform functions unclear"]},{"year":2002,"claim":"Demonstration that CK2 phosphorylation at Thr149 directs ARC to mitochondria and is required for caspase-8 binding resolved how a cytoplasmic protein gains access to its target.","evidence":"In vitro kinase assay, T149A mutagenesis, subcellular fractionation, and Co-IP","pmids":["12191471"],"confidence":"High","gaps":["Upstream signals controlling CK2-ARC axis not defined","Whether dephosphorylation reverses mitochondrial targeting unknown"]},{"year":2004,"claim":"Mapping of ARC's nonhomotypic CARD interactions with Fas/FADD death domains and Bax C-terminus unified its roles in extrinsic and intrinsic apoptosis under a single structural mechanism.","evidence":"Reciprocal Co-IP, DISC assembly assays, Bax activation/translocation assays, siRNA knockdown and overexpression","pmids":["15383280","15004034"],"confidence":"High","gaps":["No atomic-resolution structure of CARD-DD or CARD-Bax complexes","Stoichiometry and competition between targets unresolved"]},{"year":2004,"claim":"Identification of ARC as a calcium-binding protein whose P/E-rich domain binds Ca²⁺ and modulates caspase-8 interaction linked calcium homeostasis to death-pathway regulation.","evidence":"Ca²⁺ overlay assay, Stains-all, Co-IP under varying Ca²⁺, thapsigargin treatment","pmids":["15509781"],"confidence":"Medium","gaps":["Ca²⁺ binding affinity and kinetics not quantified","Structural basis for Ca²⁺-regulated interaction unknown"]},{"year":2006,"claim":"ARC knockout mice revealed that endogenous ARC is dispensable for development but essential for cardioprotection under ischemic and biomechanical stress, validating the in vitro anti-apoptotic function in vivo.","evidence":"ARC-null mice subjected to aortic banding and ischemia/reperfusion, plus human failing heart tissue analysis","pmids":["16505176"],"confidence":"High","gaps":["Neuronal phenotypes in ARC-null mice not characterized","Redundancy with other anti-apoptotic CARD proteins not explored"]},{"year":2006,"claim":"Discovery that MDM2 ubiquitinates ARC for proteasomal degradation, and that ubiquitin-site mutants stabilize ARC and enhance cytoprotection, established post-translational turnover as a key regulatory axis.","evidence":"Pulse-chase, ubiquitin acceptor mutagenesis, MDM2 RING mutant, MDM2-null cell rescue","pmids":["17142452","17142834"],"confidence":"High","gaps":["Additional E3 ligases not excluded","Deubiquitinase for ARC not identified"]},{"year":2007,"claim":"Finding that nuclear ARC binds the p53 tetramerization domain and triggers Crm1-dependent p53 export revealed a pro-oncogenic function distinct from its canonical anti-apoptotic role.","evidence":"Co-IP, nuclear/cytoplasmic fractionation, leptomycin B treatment, ARC siRNA in breast cancer cells","pmids":["18087040"],"confidence":"High","gaps":["How ARC gains nuclear entry in cancer cells not resolved","Structural interface between ARC CARD and p53 tetramerization domain unmapped"]},{"year":2010,"claim":"Demonstration that Ras-MEK/ERK signaling transcriptionally and post-translationally upregulates ARC connected oncogenic signaling to ARC-mediated survival and cell-cycle progression.","evidence":"Activated Ras overexpression, MEK inhibitor, promoter reporter, ubiquitination assay, transgenic mouse","pmids":["20392691"],"confidence":"High","gaps":["Direct transcription factor binding NOL3 promoter not identified","Whether other oncogenic pathways converge on ARC unclear"]},{"year":2012,"claim":"Identification of a NOL3 mutation cosegregating with familial cortical myoclonus linked ARC dysfunction to a Mendelian neurological disorder, extending its physiological relevance beyond the heart.","evidence":"Linkage mapping, targeted sequencing, Sanger validation, in vitro PTM assay in a 4-generation family","pmids":["22926851"],"confidence":"Medium","gaps":["Precise functional consequence of the mutation on ARC activity in neurons not defined","No animal model recapitulating the myoclonus phenotype"]},{"year":2014,"claim":"Proof that ARC blocks TNFα-induced necrosis via its CARD domain by disrupting RIP1 recruitment to TNFR1 expanded its role from an apoptosis inhibitor to a general cell death suppressor.","evidence":"ARC overexpression/knockdown, CARD mutagenesis, TNFR1-RIP1 Co-IP, in vivo vaccinia virus model","pmids":["24440909"],"confidence":"High","gaps":["Whether ARC modulates MLKL-dependent necroptosis downstream of RIPK3 not tested","Relative contribution of anti-necrotic vs anti-apoptotic activity in vivo unknown"]},{"year":2015,"claim":"Characterization of ARC-null skeletal muscle revealed caspase-independent, AIF-mediated apoptosis and mitochondrial calcium vulnerability, showing ARC protects against non-canonical apoptotic pathways.","evidence":"ARC knockout mice, muscle contractility, TUNEL, subcellular fractionation for AIF, isolated mitochondrial calcium stress","pmids":["25596718"],"confidence":"High","gaps":["Direct ARC-AIF interaction not demonstrated","Whether fiber-type shift is cell-autonomous not established"]},{"year":null,"claim":"Structural basis of ARC's nonhomotypic CARD interactions with death domains, Bax, and p53, the mechanism of its nuclear import in cancer cells, and the identity of transcription factors directly driving NOL3 expression downstream of Ras-ERK remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of ARC or its complexes","Nuclear import signal or carrier for ARC in cancer not identified","Transcription factor occupancy at NOL3 promoter not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,5,6,18]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[5,13]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2,6,19]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,13]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,8]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,5,6,9,18,19]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[15,21]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,16]}],"complexes":[],"partners":["CASP8","BAX","FAS","FADD","TNFR1","TP53","MDM2","RIPK1"],"other_free_text":[]},"mechanistic_narrative":"NOL3 (ARC) is a CARD-domain-containing inhibitor of programmed cell death that protects terminally differentiated cells—particularly cardiomyocytes, skeletal myocytes, and neurons—from apoptotic and necrotic stimuli. Its N-terminal CARD engages in nonhomotypic interactions with the death domains of Fas, FADD, TNFR1, and the pro-apoptotic effector Bax, thereby blocking both extrinsic DISC assembly and intrinsic mitochondrial cytochrome c release, as well as TNFα-induced necrosis by preventing RIP1 recruitment to TNFR1 [PMID:15383280, PMID:24440909]. CK2-mediated phosphorylation at Thr149 targets ARC to mitochondria and is required for caspase-8 binding, while MDM2-dependent ubiquitin-proteasomal degradation and Ras-MEK/ERK-driven transcriptional and post-translational stabilization set its steady-state levels [PMID:12191471, PMID:17142834, PMID:20392691]. In cancer cells ARC accumulates in the nucleus where it binds the p53 tetramerization domain, triggering Crm1-dependent p53 nuclear export and functional inactivation, promoting tumor growth, chemoresistance, and metastasis [PMID:18087040, PMID:22037876]."},"prefetch_data":{"uniprot":{"accession":"O60936","full_name":"Nucleolar protein 3","aliases":["Apoptosis repressor with CARD","Muscle-enriched cytoplasmic protein","Myp","Nucleolar protein of 30 kDa","Nop30"],"length_aa":208,"mass_kda":22.6,"function":"May be involved in RNA splicing Functions as an apoptosis repressor that blocks multiple modes of cell death. Inhibits extrinsic apoptotic pathways through two different ways. Firstly by interacting with FAS and FADD upon FAS activation blocking death-inducing signaling complex (DISC) assembly (By similarity). Secondly by interacting with CASP8 in a mitochondria localization- and phosphorylation-dependent manner, limiting the amount of soluble CASP8 available for DISC-mediated activation (By similarity). Inhibits intrinsic apoptotic pathway in response to a wide range of stresses, through its interaction with BAX resulting in BAX inactivation, preventing mitochondrial dysfunction and release of pro-apoptotic factors (PubMed:15004034). Inhibits calcium-mediated cell death by functioning as a cytosolic calcium buffer, dissociating its interaction with CASP8 and maintaining calcium homeostasis (PubMed:15509781). Negatively regulates oxidative stress-induced apoptosis by phosphorylation-dependent suppression of the mitochondria-mediated intrinsic pathway, by blocking CASP2 activation and BAX translocation (By similarity). Negatively regulates hypoxia-induced apoptosis in part by inhibiting the release of cytochrome c from mitochondria in a caspase-independent manner (By similarity). Also inhibits TNF-induced necrosis by preventing TNF-signaling pathway through TNFRSF1A interaction abrogating the recruitment of RIPK1 to complex I (By similarity). Finally through its role as apoptosis repressor, promotes vascular remodeling through inhibition of apoptosis and stimulation of proliferation, in response to hypoxia (By similarity). Inhibits too myoblast differentiation through caspase inhibition (By similarity)","subcellular_location":"Cytoplasm; Mitochondrion; Sarcoplasmic reticulum; Membrane","url":"https://www.uniprot.org/uniprotkb/O60936/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NOL3","classification":"Not Classified","n_dependent_lines":12,"n_total_lines":1208,"dependency_fraction":0.009933774834437087},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NOL3","total_profiled":1310},"omim":[{"mim_id":"614937","title":"MYOCLONUS, FAMILIAL, 1; MYOCL1","url":"https://www.omim.org/entry/614937"},{"mim_id":"611462","title":"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 6; PIK3R6","url":"https://www.omim.org/entry/611462"},{"mim_id":"605235","title":"NUCLEOLAR PROTEIN 3; NOL3","url":"https://www.omim.org/entry/605235"},{"mim_id":"604593","title":"KINESIN FAMILY MEMBER 5C; KIF5C","url":"https://www.omim.org/entry/604593"},{"mim_id":"602821","title":"KINESIN FAMILY MEMBER 5A; KIF5A","url":"https://www.omim.org/entry/602821"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NOL3"},"hgnc":{"alias_symbol":["ARC","NOP30","MYP","CARD2"],"prev_symbol":[]},"alphafold":{"accession":"O60936","domains":[{"cath_id":"1.10.533.10","chopping":"9-87","consensus_level":"high","plddt":96.1324,"start":9,"end":87}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60936","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60936-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60936-F1-predicted_aligned_error_v6.png","plddt_mean":71.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NOL3","jax_strain_url":"https://www.jax.org/strain/search?query=NOL3"},"sequence":{"accession":"O60936","fasta_url":"https://rest.uniprot.org/uniprotkb/O60936.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60936/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60936"}},"corpus_meta":[{"pmid":"17088211","id":"PMC_17088211","title":"Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking.","date":"2006","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/17088211","citation_count":624,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20211139","id":"PMC_20211139","title":"The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/20211139","citation_count":511,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21278731","id":"PMC_21278731","title":"New views of Arc, a master regulator of synaptic plasticity.","date":"2011","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21278731","citation_count":398,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29328916","id":"PMC_29328916","title":"The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/29328916","citation_count":381,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19690847","id":"PMC_19690847","title":"The Arc of synaptic memory.","date":"2009","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/19690847","citation_count":369,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10235267","id":"PMC_10235267","title":"Composite co-activator ARC mediates chromatin-directed transcriptional activation.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10235267","citation_count":363,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21963089","id":"PMC_21963089","title":"Arc in synaptic plasticity: from gene to behavior.","date":"2011","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/21963089","citation_count":300,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19187770","id":"PMC_19187770","title":"The geometry of leptin action in the brain: more complicated than a simple ARC.","date":"2009","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19187770","citation_count":231,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27869800","id":"PMC_27869800","title":"A rapidly acting glutamatergic ARC→PVH satiety circuit postsynaptically regulated by α-MSH.","date":"2016","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27869800","citation_count":213,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20921410","id":"PMC_20921410","title":"Arc regulates spine morphology and maintains network stability in vivo.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20921410","citation_count":212,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16020527","id":"PMC_16020527","title":"Memory-influencing intra-basolateral amygdala drug infusions modulate expression of Arc protein in the hippocampus.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16020527","citation_count":205,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20189687","id":"PMC_20189687","title":"Age-related changes in Arc transcription and DNA methylation within the hippocampus.","date":"2010","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/20189687","citation_count":167,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28890419","id":"PMC_28890419","title":"Arc protein: a flexible hub for synaptic plasticity and cognition.","date":"2017","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28890419","citation_count":138,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12167862","id":"PMC_12167862","title":"A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.","date":"2002","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12167862","citation_count":135,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25864631","id":"PMC_25864631","title":"Structural basis of arc binding to synaptic proteins: implications for cognitive disease.","date":"2015","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/25864631","citation_count":135,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23749147","id":"PMC_23749147","title":"Arc in the nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity.","date":"2013","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23749147","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26051420","id":"PMC_26051420","title":"Motor Learning Consolidates Arc-Expressing Neuronal Ensembles in Secondary Motor Cortex.","date":"2015","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/26051420","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20592749","id":"PMC_20592749","title":"Time-dependent expression of Arc and zif268 after acquisition of fear conditioning.","date":"2010","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/20592749","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24945773","id":"PMC_24945773","title":"Triad3A regulates synaptic strength by ubiquitination of Arc.","date":"2014","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/24945773","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36007055","id":"PMC_36007055","title":"The genetic history of the Southern Arc: A bridge between West Asia and Europe.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/36007055","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17998337","id":"PMC_17998337","title":"p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17998337","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18430620","id":"PMC_18430620","title":"UV-enhanced bioactivity and cell response of micro-arc oxidized titania coatings.","date":"2008","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/18430620","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16896922","id":"PMC_16896922","title":"Clinical and molecular genetic features of ARC syndrome.","date":"2006","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16896922","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22844515","id":"PMC_22844515","title":"MicroRNA regulation of the synaptic plasticity-related gene Arc.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22844515","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25628532","id":"PMC_25628532","title":"Localization and local translation of Arc/Arg3.1 mRNA at synapses: some observations and paradoxes.","date":"2015","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25628532","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19278724","id":"PMC_19278724","title":"Arachidonic acid, ARC channels, and Orai proteins.","date":"2009","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/19278724","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29861284","id":"PMC_29861284","title":"The Temporal Dynamics of Arc Expression Regulate Cognitive Flexibility.","date":"2018","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/29861284","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2995361","id":"PMC_2995361","title":"The bacteriophage P22 arc and mnt repressors. Overproduction, purification, and properties.","date":"1985","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2995361","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29689050","id":"PMC_29689050","title":"Activation of temperature-sensitive TRPV1-like receptors in ARC POMC neurons reduces food intake.","date":"2018","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/29689050","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17142834","id":"PMC_17142834","title":"Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17142834","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15546853","id":"PMC_15546853","title":"ARC channels: a novel pathway for receptor-activated calcium entry.","date":"2004","source":"Physiology (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15546853","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30827484","id":"PMC_30827484","title":"Adolescent Alcohol Exposure Epigenetically Suppresses Amygdala Arc Enhancer RNA Expression to Confer Adult Anxiety Susceptibility.","date":"2019","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30827484","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10698012","id":"PMC_10698012","title":"Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites.","date":"2000","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10698012","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25748042","id":"PMC_25748042","title":"Arc is a flexible modular protein capable of reversible self-oligomerization.","date":"2015","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/25748042","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17391754","id":"PMC_17391754","title":"STIM1 and the noncapacitative ARC channels.","date":"2007","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/17391754","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15898065","id":"PMC_15898065","title":"Immediate early gene (ZENK, Arc) expression in the auditory forebrain of female canaries varies in response to male song quality.","date":"2005","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/15898065","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30674535","id":"PMC_30674535","title":"An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30674535","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24776996","id":"PMC_24776996","title":"Connecting ears to eye muscles: evolution of a 'simple' reflex arc.","date":"2014","source":"Brain, behavior and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/24776996","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15509781","id":"PMC_15509781","title":"Calcium binding of ARC mediates regulation of caspase 8 and cell death.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15509781","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22037876","id":"PMC_22037876","title":"Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22037876","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26474411","id":"PMC_26474411","title":"Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26474411","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30442670","id":"PMC_30442670","title":"Arc/Arg3.1 mediates a critical period for spatial learning and hippocampal networks.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30442670","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31919348","id":"PMC_31919348","title":"Arc silence aggravates traumatic neuronal injury via mGluR1-mediated ER stress and necroptosis.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31919348","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25239142","id":"PMC_25239142","title":"Arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome: from molecular genetics to clinical features.","date":"2014","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/25239142","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28943393","id":"PMC_28943393","title":"Regulation of spine structural plasticity by Arc/Arg3.1.","date":"2017","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28943393","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34380037","id":"PMC_34380037","title":"An mPOA-ARCAgRP pathway modulates cold-evoked eating behavior.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34380037","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21320587","id":"PMC_21320587","title":"Neuroinflammation and the plasticity-related immediate-early gene Arc.","date":"2011","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/21320587","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10196175","id":"PMC_10196175","title":"Alternative splicing determines the intracellular localization of the novel nuclear protein Nop30 and its interaction with the splicing factor SRp30c.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10196175","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25783003","id":"PMC_25783003","title":"Enhancement of dynamin polymerization and GTPase activity by Arc/Arg3.1.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25783003","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26612866","id":"PMC_26612866","title":"The autoinhibitory CARD2-Hel2i Interface of RIG-I governs RNA selection.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26612866","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28890422","id":"PMC_28890422","title":"Transcriptional and post-translational regulation of Arc in synaptic plasticity.","date":"2017","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28890422","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28890421","id":"PMC_28890421","title":"The mechanistic link between Arc/Arg3.1 expression and AMPA receptor endocytosis.","date":"2017","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28890421","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18516683","id":"PMC_18516683","title":"Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC.","date":"2008","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/18516683","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29635031","id":"PMC_29635031","title":"Sleep loss disrupts Arc expression in dentate gyrus neurons.","date":"2018","source":"Neurobiology of learning and memory","url":"https://pubmed.ncbi.nlm.nih.gov/29635031","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28108859","id":"PMC_28108859","title":"The Arc Gene Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/28108859","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24012642","id":"PMC_24012642","title":"Involvement of hippocampal Arc in amnesia and its recovery by alcoholic extract of Ashwagandha leaves.","date":"2013","source":"Neurobiology of learning and memory","url":"https://pubmed.ncbi.nlm.nih.gov/24012642","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20392691","id":"PMC_20392691","title":"Induction of the apoptosis inhibitor ARC by Ras in human cancers.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20392691","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16309632","id":"PMC_16309632","title":"Regulation of activity-regulated cytoskeleton protein (Arc) mRNA after acute and chronic electroconvulsive stimulation in the rat.","date":"2005","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/16309632","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28670266","id":"PMC_28670266","title":"GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28670266","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24367308","id":"PMC_24367308","title":"Differential activation of amygdala Arc expression by positive and negatively valenced emotional learning conditions.","date":"2013","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24367308","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36009494","id":"PMC_36009494","title":"Arc Regulates Transcription of Genes for Plasticity, Excitability and Alzheimer's Disease.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/36009494","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31118786","id":"PMC_31118786","title":"Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).","date":"2019","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/31118786","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28890418","id":"PMC_28890418","title":"Arc ubiquitination in synaptic plasticity.","date":"2017","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28890418","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27496733","id":"PMC_27496733","title":"ARC Syndrome-Linked Vps33B Protein Is Required for Inflammatory Endosomal Maturation and Signal Termination.","date":"2016","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27496733","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12781975","id":"PMC_12781975","title":"Cleavage site of a major yolk protein (MYP) determined by cDNA isolation and amino acid sequencing in sea urchin, Hemicentrotus pulcherrimus.","date":"2003","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12781975","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22201777","id":"PMC_22201777","title":"STIM and Orai proteins and the non-capacitative ARC channels.","date":"2012","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/22201777","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30154698","id":"PMC_30154698","title":"Position- and Time-Dependent Arc Expression Links Neuronal Activity to Synaptic Plasticity During Epileptogenesis.","date":"2018","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30154698","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26464965","id":"PMC_26464965","title":"A Neuronal Activity-Dependent Dual Function Chromatin-Modifying Complex Regulates Arc Expression.","date":"2015","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/26464965","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18704370","id":"PMC_18704370","title":"Basal and stress-induced modulation of activity-regulated cytoskeletal associated protein (Arc) in the rat brain following duloxetine treatment.","date":"2008","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18704370","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32350140","id":"PMC_32350140","title":"Loss of Arc attenuates the behavioral and molecular responses for sleep homeostasis in mice.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32350140","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34326146","id":"PMC_34326146","title":"Intercellular Arc Signaling Regulates Vasodilation.","date":"2021","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34326146","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36073248","id":"PMC_36073248","title":"Molecular physiology of Arc/Arg3.1: The oligomeric state hypothesis of synaptic plasticity.","date":"2022","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/36073248","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33604728","id":"PMC_33604728","title":"Role of apoptosis repressor with caspase recruitment domain (ARC) in cell death and cardiovascular disease.","date":"2021","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/33604728","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23744421","id":"PMC_23744421","title":"Changes in the Egr1 and Arc expression in brain structures of pentylenetetrazole-kindled rats.","date":"2013","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/23744421","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33250721","id":"PMC_33250721","title":"Activation of the ARCPOMC→MeA Projection Reduces Food Intake.","date":"2020","source":"Frontiers in neural circuits","url":"https://pubmed.ncbi.nlm.nih.gov/33250721","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12753927","id":"PMC_12753927","title":"Down-regulation of ARC contributes to vulnerability of hippocampal neurons to ischemia/hypoxia.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12753927","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28941877","id":"PMC_28941877","title":"Arc - An endogenous neuronal retrovirus?","date":"2017","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28941877","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33383707","id":"PMC_33383707","title":"Effects of Ketamine on Learning and Memory in the Hippocampus of Rats through ERK, CREB, and Arc.","date":"2020","source":"Brain sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33383707","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19450491","id":"PMC_19450491","title":"Arc-repressor dimerization on DNA: folding rate enhancement by colocalization.","date":"2009","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19450491","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22071872","id":"PMC_22071872","title":"Altered learning and Arc-regulated consolidation of learning in striatum by methamphetamine-induced neurotoxicity.","date":"2011","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22071872","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31474829","id":"PMC_31474829","title":"Secreted Amyloid Precursor Protein-Alpha Promotes Arc Protein Synthesis in Hippocampal Neurons.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31474829","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29803152","id":"PMC_29803152","title":"Effect of vanadium released from micro-arc oxidized porous Ti6Al4V on biocompatibility in orthopedic applications.","date":"2018","source":"Colloids and surfaces. B, Biointerfaces","url":"https://pubmed.ncbi.nlm.nih.gov/29803152","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27464451","id":"PMC_27464451","title":"Rare mutations and hypermethylation of the ARC gene associated with schizophrenia.","date":"2016","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/27464451","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11085305","id":"PMC_11085305","title":"Activation of an effector immediate-early gene arc by methamphetamine.","date":"2000","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/11085305","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31907539","id":"PMC_31907539","title":"The continuing arc toward phototropic enlightenment.","date":"2020","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/31907539","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24440909","id":"PMC_24440909","title":"A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosis.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24440909","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22926851","id":"PMC_22926851","title":"Familial cortical myoclonus with a mutation in NOL3.","date":"2012","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22926851","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27221790","id":"PMC_27221790","title":"Tat-NOL3 protects against hippocampal neuronal cell death induced by oxidative stress through the regulation of apoptotic pathways.","date":"2016","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27221790","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28593137","id":"PMC_28593137","title":"MSK1 regulates transcriptional induction of Arc/Arg3.1 in response to neurotrophins.","date":"2017","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/28593137","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17724478","id":"PMC_17724478","title":"Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17724478","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28970817","id":"PMC_28970817","title":"Community Structure of Lithotrophically-Driven Hydrothermal Microbial Mats from the Mariana Arc and Back-Arc.","date":"2017","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28970817","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29162813","id":"PMC_29162813","title":"Chemogenomic analysis reveals key role for lysine acetylation in regulating Arc stability.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29162813","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36796600","id":"PMC_36796600","title":"NMDA Receptor-Arc Signaling Is Required for Memory Updating and Is Disrupted in Alzheimer's Disease.","date":"2023","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/36796600","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30902368","id":"PMC_30902368","title":"Membrane Morphologies Induced by Arc-Shaped Scaffolds Are Determined by Arc Angle and Coverage.","date":"2019","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/30902368","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23877130","id":"PMC_23877130","title":"ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.","date":"2013","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23877130","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25596718","id":"PMC_25596718","title":"Functional, morphological, and apoptotic alterations in skeletal muscle of ARC deficient mice.","date":"2015","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/25596718","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12617955","id":"PMC_12617955","title":"The activity-regulated cytoskeleton-associated (Arc) gene is a new light-inducible early gene in the mouse suprachiasmatic nucleus.","date":"2003","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12617955","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35814106","id":"PMC_35814106","title":"Wired to Connect: The Autonomic Socioemotional Reflex Arc.","date":"2022","source":"Frontiers in psychology","url":"https://pubmed.ncbi.nlm.nih.gov/35814106","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18062938","id":"PMC_18062938","title":"mRNA expression of activity-regulated cytoskeleton-associated protein (arc) in the amygdala-kindled rats.","date":"2007","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/18062938","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34603440","id":"PMC_34603440","title":"mRNA Trafficking in the Nervous System: A Key Mechanism of the Involvement of Activity-Regulated Cytoskeleton-Associated Protein (Arc) in Synaptic Plasticity.","date":"2021","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/34603440","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19490893","id":"PMC_19490893","title":"A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19490893","citation_count":843,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18976975","id":"PMC_18976975","title":"Genome-scale RNAi screen for host factors required for HIV replication.","date":"2008","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/18976975","citation_count":627,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9560245","id":"PMC_9560245","title":"ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9560245","citation_count":301,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15383280","id":"PMC_15383280","title":"Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15383280","citation_count":147,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15004034","id":"PMC_15004034","title":"Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15004034","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12191471","id":"PMC_12191471","title":"Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC.","date":"2002","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12191471","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28986522","id":"PMC_28986522","title":"Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28986522","citation_count":99,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16505176","id":"PMC_16505176","title":"Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress.","date":"2006","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/16505176","citation_count":97,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21044950","id":"PMC_21044950","title":"Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells.","date":"2010","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21044950","citation_count":93,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18087040","id":"PMC_18087040","title":"Regulation of p53 tetramerization and nuclear export by ARC.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18087040","citation_count":88,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24763054","id":"PMC_24763054","title":"MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24763054","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15342556","id":"PMC_15342556","title":"Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15342556","citation_count":57,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15848180","id":"PMC_15848180","title":"Apoptosis repressor with caspase recruitment domain (ARC) is expressed in cancer cells and localizes to nuclei.","date":"2005","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15848180","citation_count":57,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15861191","id":"PMC_15861191","title":"ARC, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo- and radiation-resistance.","date":"2005","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/15861191","citation_count":57,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26760575","id":"PMC_26760575","title":"High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.","date":"2016","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/26760575","citation_count":50,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18469522","id":"PMC_18469522","title":"ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18469522","citation_count":48,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17142452","id":"PMC_17142452","title":"The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17142452","citation_count":47,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12734105","id":"PMC_12734105","title":"Apoptosis repressor with caspase domain inhibits cardiomyocyte apoptosis by reducing K+ currents.","date":"2003","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12734105","citation_count":44,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44045,"output_tokens":3241,"usd":0.090375},"stage2":{"model":"claude-opus-4-6","input_tokens":6657,"output_tokens":3387,"usd":0.17694},"total_usd":0.585557,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":56441,"output_tokens":6728,"usd":0.135122},"round2_rules_fired":"R2","round2_stage2":{"model":"claude-opus-4-6","input_tokens":10111,"output_tokens":2861,"usd":0.18312}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"A missense mutation in NOL3 (encoding ARC, apoptosis repressor with CARD domain) co-segregates with autosomal dominant familial cortical myoclonus in a 4-generation Canadian Mennonite family, and the mutation alters post-translational modification of NOL3 protein in vitro, establishing NOL3 as the disease gene and linking its PTM regulation to neuronal hyperexcitability.\",\n      \"method\": \"SNP mapping, microsatellite linkage, targeted massively parallel sequencing, Sanger sequencing, in vitro post-translational modification assay\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic linkage with functional in vitro PTM validation; single family/lab\",\n      \"pmids\": [\"22926851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NOL3/ARC protein binds Ca²⁺ through its C-terminal proline/glutamate-rich (P/E-rich) domain; this calcium binding reduces cytosolic Ca²⁺ transients and attenuates Ca²⁺-mediated cytotoxicity, and the interaction between ARC and caspase-8 is decreased by elevated Ca²⁺ concentration both in vitro and in cells treated with thapsigargin.\",\n      \"method\": \"Ca²⁺ overlay assay, Stains-all assay, co-immunoprecipitation, ectopic expression/knockdown with cell death assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods in single study; single lab\",\n      \"pmids\": [\"15509781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The E3 ubiquitin ligase MDM2 directly ubiquitinates NOL3/ARC and promotes its proteasomal degradation in cardiomyocytes; this requires a functional MDM2 RING finger domain (C464A mutant is inactive), and oxidative stress upregulates MDM2 to reduce ARC levels.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, MDM2 knockout fibroblasts rescue experiment, MDM2 RING mutant analysis, proteasomal inhibitor rescue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct ubiquitination demonstrated with active-site mutant and KO rescue; multiple orthogonal methods\",\n      \"pmids\": [\"17142834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"p53 transcriptionally represses NOL3/ARC expression in response to reactive oxygen species and anoxia; ARC interacts with PUMA and Bad via its N-terminus, displacing their association with Bcl-2, and p53-induced loss of ARC releases PUMA/Bad to promote apoptosis.\",\n      \"method\": \"p53 knockdown, mRNA/protein level measurement, transcription-dependent repression assay, co-immunoprecipitation/binding assay with PUMA and Bad\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods; single lab showing transcriptional and protein-interaction mechanisms\",\n      \"pmids\": [\"17998337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NOL3/ARC inhibits TNFα-induced regulated necrosis by interacting with TNF receptor 1, thereby interfering with recruitment of RIP1; this anti-necrotic function requires an intact CARD domain, and ARC depletion in vivo exacerbates vaccinia virus-induced necrosis and TNFα-induced systemic inflammatory response syndrome.\",\n      \"method\": \"Overexpression/knockdown of ARC, CARD domain mutant analysis, co-immunoprecipitation with TNFR1, in vivo mouse models\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, domain mutant, in vivo rescue; multiple orthogonal approaches in single study\",\n      \"pmids\": [\"24440909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ras induces NOL3/ARC expression in epithelial cancers through MEK/ERK-dependent activation of the Nol3 promoter and also stabilizes ARC protein by suppressing its polyubiquitination and proteasomal degradation; ARC in turn mediates Ras-induced cell survival and cell cycle progression.\",\n      \"method\": \"Ras overexpression/knockdown, promoter-reporter assay, ubiquitination assay, transgenic mouse mammary model, mRNA and protein quantification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — promoter assay, ubiquitination assay, in vivo transgenic model; multiple orthogonal methods\",\n      \"pmids\": [\"20392691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Alternative splicing of the NOL3/NOP30 gene produces two isoforms with different C-termini: one (Nop30) containing an SR-rich C-terminus that localizes to the nucleoplasm/nucleolus and binds the RS domain of splicing factor SRp30c, and one with a proline/glutamic acid-rich C-terminus that resides predominantly in the cytosol; Nop30 overexpression alters alternative exon usage in reporter genes.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro protein interaction assay, co-immunoprecipitation, transfection/overexpression, alternative splicing reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding assays, subcellular localization with functional consequence (splicing), multiple methods in single study\",\n      \"pmids\": [\"10196175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NOL3/ARC deficiency in mice causes functional and morphological alterations in slow/oxidative skeletal muscle, including reduced maximum tetanic force, fiber-type shift toward type II, decreased cross-sectional area, increased DNA fragmentation, elevated cytosolic apoptosis-inducing factor (AIF), and increased mitochondrial susceptibility to calcium stress—indicating caspase-independent, mitochondria-mediated apoptotic signaling.\",\n      \"method\": \"ARC knockout mouse, force measurements, fiber-type immunostaining, TUNEL/DNA fragmentation assay, AIF western blot, isolated mitochondria calcium stress assay\",\n      \"journal\": \"Apoptosis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and functional phenotypes; single lab, multiple readouts\",\n      \"pmids\": [\"25596718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Deletion of the nol3 gene (encoding ARC) in the PyMT transgenic mouse model of breast cancer reduces primary tumor burden, decreases tumor cell invasion and circulating cancer cells, and markedly reduces lung metastases; ectopic ARC overexpression in metastatic breast cancer cells increases invasion in vitro and lung metastasis in vivo, and endogenous ARC levels confer chemoresistance.\",\n      \"method\": \"Gene knockout in transgenic mouse model, ectopic overexpression, RNAi knockdown, orthotopic xenograft, invasion assays, in vivo metastasis quantification\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional gain/loss of function in both mouse and human models; multiple orthogonal readouts\",\n      \"pmids\": [\"22037876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Tat-fused NOL3 protein transduces into HT22 hippocampal neurons and brain tissue and protects against H₂O₂-induced oxidative stress by reducing ROS production, preventing DNA fragmentation, maintaining mitochondrial membrane potential, and regulating apoptotic signaling pathways (Bax, Bcl-2, caspase-2, -3, -8, PARP, p53); it also reduces neuronal cell death in the CA1 hippocampal region in a forebrain ischemia animal model.\",\n      \"method\": \"Tat-fusion protein transduction, ROS measurement, DNA fragmentation assay, mitochondrial membrane potential assay, western blotting of apoptotic proteins, in vivo ischemia model with immunohistochemistry\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vitro and in vivo methods; single lab\",\n      \"pmids\": [\"27221790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In AML, NOL3/ARC regulates an IL1β/Cox-2/PGE2/β-catenin circuit: ARC promotes IL1β release from leukemia cells, which induces Cox-2 expression and PGE2 production in mesenchymal stromal cells; PGE2 activates β-catenin which in turn upregulates ARC expression, conferring chemoresistance. In vivo ARC knockdown reduces leukemia burden, lowers serum IL1β/PGE2, and increases chemotherapy sensitivity.\",\n      \"method\": \"AML-MSC co-culture, Cox-2/PGE2 measurement, β-catenin inhibition, ARC knockdown, NOD/SCID mouse xenograft model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo mechanistic circuit defined with multiple pathway interventions; single lab\",\n      \"pmids\": [\"30674535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NOL3/ARC expression is substantially reduced in the CA1 hippocampal region following transient global ischemia in vivo and hypoxia in vitro; forced expression of ARC significantly reduces hypoxia-induced neuronal cell death, and the C-terminal P/E-rich region of ARC is specifically required for this neuroprotective effect.\",\n      \"method\": \"In vivo ischemia model, hypoxia cell culture, western blotting, forced overexpression with domain deletion constructs, cell viability assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain-level functional dissection with loss- and gain-of-function; single lab\",\n      \"pmids\": [\"12753927\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOL3 (ARC/apoptosis repressor with CARD domain) is a multifunctional anti-apoptotic protein, highly expressed in postmitotic cells (cardiomyocytes, neurons, skeletal muscle), that inhibits both extrinsic apoptosis (by blocking caspase-8 and TNFR1-RIP1 recruitment), intrinsic/mitochondrial apoptosis (by interacting with PUMA and Bad to sequester them from Bcl-2), and TNFα-induced necrosis via a CARD-dependent interaction with TNFR1; its protein levels are regulated by MDM2-mediated ubiquitination/proteasomal degradation (promoted by p53 and oxidative stress), Ras/MEK/ERK-dependent transcriptional induction, and Ca²⁺-dependent modulation of its interaction with caspase-8; alternative splicing generates a nucleolar/nuclear isoform (Nop30) that binds the splicing factor SRp30c and influences alternative splicing, while a cytosolic isoform carries a proline/glutamate-rich C-terminus responsible for Ca²⁺ binding and neuroprotection; loss-of-function studies in mice reveal roles in cardiac protection, skeletal muscle maintenance, tumor suppression, and neuronal survival, and a dominant NOL3 mutation causing altered PTM underlies familial cortical myoclonus.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper and extract discoveries only from KEPT papers about NOL3 (Apoptosis Repressor with Caspase Recruitment Domain, ARC).\n\n**Classification:**\n- Papers about Arc/Arg3.1 (neuronal immediate early gene, synaptic plasticity protein) → EXCLUDE (different gene, symbol collision)\n- Papers about ARC channels (arachidonic acid-regulated Ca2+ channels) → EXCLUDE (different entity)\n- Papers about ARC syndrome (VPS33B mutations) → EXCLUDE (different gene)\n- Papers about ARC/Mediator complex → EXCLUDE (different entity)\n- Papers about bacteriophage P22 Arc repressor → EXCLUDE (symbol collision)\n- Papers about NOL3/ARC (apoptosis repressor with CARD domain, encoded by NOL3 gene) → KEEP\n- Large interactome/genomic screens → KEEP only if NOL3 is specifically characterized\n\n**KEPT papers:** PMID:9560245, PMID:15383280, PMID:15004034, PMID:12191471, PMID:16505176, PMID:17142834, PMID:17998337, PMID:18087040, PMID:15509781, PMID:17142452, PMID:12734105, PMID:22037876, PMID:20392691, PMID:30674535, PMID:86 (24440909), PMID:22926851, PMID:27221790, PMID:25596718, PMID:23877130, PMID:15848180, PMID:15861191, PMID:18516683, PMID:12753927, PMID:33604728, PMID:10196175 (Nop30/NOL3 isoform - KEEP)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"NOL3/ARC was identified as a novel apoptosis inhibitor containing an N-terminal CARD domain fused to a C-terminal proline/glutamic acid-rich region, expressed predominantly in skeletal muscle and cardiac tissue. Immunoprecipitation showed ARC interacts selectively with caspase-2, caspase-8, and C. elegans CED-3, but not caspase-1, -3, or -9. ARC inhibited caspase-8 enzymatic activity and blocked apoptosis induced by FADD, TRADD, and death receptors CD95/Fas, TNF-R1, and TRAMP/DR3.\",\n      \"method\": \"Immunoprecipitation, caspase activity assays, overexpression in 293T cells, death receptor stimulation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original discovery paper with multiple orthogonal methods (Co-IP, enzymatic assay, functional rescue), highly cited foundational study\",\n      \"pmids\": [\"9560245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Alternative splicing of the NOL3/NOP gene produces two isoforms with different C-terminal ends and distinct subcellular localizations: Nop30 (nuclear/nucleolar) and a cytosolic isoform with a proline/glutamic acid-rich C-terminus. Nop30 multimerizes and binds the RS domain of splicing factor SRp30c but not other splicing factors tested. Overexpression of Nop30 alters alternative exon usage in preprotachykinin and SRp20 reporter genes.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro protein interaction assays, co-immunoprecipitation, overexpression reporter assays, immunofluorescence localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple methods (Y2H, Co-IP, functional reporter) in single study; describes NOL3 isoform biology\",\n      \"pmids\": [\"10196175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ARC function is regulated by protein kinase CK2, which phosphorylates ARC at threonine 149. This phosphorylation targets ARC to mitochondria. ARC can only bind caspase-8 when localized to mitochondria, not in the cytoplasm, establishing phosphorylation-dependent subcellular localization as a prerequisite for caspase inhibition.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, subcellular fractionation, co-immunoprecipitation, overexpression\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay with mutagenesis plus localization and interaction studies, replicated across conditions\",\n      \"pmids\": [\"12191471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ARC expression is reduced in the CA1 hippocampal region following transient global ischemia, coinciding with TUNEL-positive cell death. Forced expression of ARC in hippocampal neurons or B103 neuronal cells significantly reduced hypoxia-induced cell death, with the C-terminal P/E-rich region being effective in attenuating hypoxic insults.\",\n      \"method\": \"Western blotting, immunohistochemistry, TUNEL assay, forced expression in primary neuronal cultures and neuronal cell lines\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — loss-of-function correlative plus gain-of-function in neurons; domain mapping with C-terminal region\",\n      \"pmids\": [\"12753927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ARC inhibits cardiomyocyte apoptosis in part by reducing K+ efflux through voltage-gated K+ (Kv) channels. Overexpression of ARC in H9c2 cells significantly decreased Kv currents, and suppressed the staurosporine-induced increase in Kv currents and subsequent apoptosis.\",\n      \"method\": \"Whole-cell patch clamp electrophysiology, overexpression in H9c2 cells, staurosporine-induced apoptosis assay\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct electrophysiology with overexpression; single lab, single cell line\",\n      \"pmids\": [\"12734105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ARC inhibits both extrinsic and intrinsic apoptosis pathways through nonhomotypic death-fold interactions. ARC's CARD domain engages heterotypic interactions with the death domains (DDs) of Fas and FADD, blocking Fas-FADD binding and DISC assembly. ARC also binds Bax via its CARD domain interacting with the Bax C-terminus, inhibiting Bax activation and mitochondrial translocation. Knockdown of endogenous ARC facilitates DISC assembly and triggers spontaneous Bax activation.\",\n      \"method\": \"Co-immunoprecipitation, DISC assembly assays, Bax activation assays, siRNA knockdown, overexpression\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (reciprocal Co-IP, DISC assay, Bax translocation, KD and OE), strong mechanistic resolution of nonhomotypic CARD interactions\",\n      \"pmids\": [\"15383280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ARC co-immunoprecipitates with Bax and prevents Bax activation and cytochrome c release in hydrogen peroxide-treated H9c2 cells. The CARD domain of ARC (L31F mutant defective) is required for this interaction. Recombinant ARC protein abrogated Bax-induced cytochrome c release from isolated mitochondria. TAT-ARC transduction blocked cytochrome c release after ischemia/reperfusion.\",\n      \"method\": \"Co-immunoprecipitation, TAT-fusion protein transduction, isolated mitochondria assay, cytochrome c release assay, in vivo ischemia/reperfusion model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution with isolated mitochondria plus mutagenesis (L31F) plus in vivo validation\",\n      \"pmids\": [\"15004034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ARC is a Ca2+-dependent regulator of caspase-8 and cell death. ARC protein binds Ca2+ through its C-terminal proline/glutamic acid-rich (P/E-rich) domain as shown by Ca2+ overlay and Stains-all assays. ARC expression reduces cytosolic Ca2+ transients and protects against Ca2+-mediated cytotoxicity. The protein-protein interaction between ARC and caspase-8 is decreased by elevated Ca2+ concentration in vitro and by thapsigargin treatment in vivo, linking calcium binding to regulation of caspase-8 inhibition.\",\n      \"method\": \"Ca2+ overlay assay, Stains-all staining, co-immunoprecipitation, siRNA knockdown, cell death assays with Ca2+ ionophores/thapsigargin\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple assays (Ca2+ binding, Co-IP, functional), single lab\",\n      \"pmids\": [\"15509781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ARC is expressed at high levels in various non-myogenic and non-neurogenic human and rat cancer cell lines. In cancer cells, ARC localizes almost exclusively to the nucleus, unlike its cytoplasmic localization in non-cancer cells. Nuclear ARC in cancer cells does not co-localize with the Nop30 isoform (nucleolar).\",\n      \"method\": \"Immunofluorescence, subcellular fractionation, Western blotting in multiple cancer cell lines\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization experiments across multiple cell lines; functional implication of nuclear ARC distinct from cytoplasmic\",\n      \"pmids\": [\"15848180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ARC-deficient mice develop normally but show accelerated cardiomyopathy under biomechanical stress (aortic banding) and markedly increased myocardial infarct sizes after ischemia/reperfusion. Increased apoptotic cardiomyocytes were observed in ARC-deficient mice under both stress conditions. ARC protein levels are markedly reduced in failing human hearts. ARC had no effect on hypertrophic cardiomyocyte growth responses.\",\n      \"method\": \"ARC knockout mouse generation, aortic banding model, ischemia/reperfusion model, cardiac function measurements, apoptosis assays, human heart tissue analysis\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mouse with defined cardiac phenotypes under two distinct stress conditions, plus human tissue validation\",\n      \"pmids\": [\"16505176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ARC protein degradation is mediated by the ubiquitin-proteasomal pathway in response to death stimuli. Mutation of ARC ubiquitin acceptor residues stabilizes ARC protein, preserves its steady-state levels during apoptosis, and improves cytoprotection. Decreases in ARC protein levels during apoptosis are post-translational (not transcriptional) and constitute a trigger rather than a consequence of cell death.\",\n      \"method\": \"Pulse-chase experiments, ubiquitin acceptor site mutagenesis, proteasome inhibitor treatment, apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis of ubiquitin sites plus pulse-chase plus functional rescue; mechanistic causality established\",\n      \"pmids\": [\"17142452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MDM2 is a critical regulator of ARC protein levels in cardiomyocytes. Oxidative stress reduces ARC levels while upregulating MDM2. MDM2 directly accelerates ARC protein turnover via ubiquitination and proteasomal degradation, requiring a functioning MDM2 RING finger domain (C464A mutant cannot direct ARC degradation). MDM2 knockout fibroblasts show defective ARC degradation rescued by MDM2 reconstitution.\",\n      \"method\": \"MDM2 overexpression and knockdown, MDM2 C464A mutant, MDM2 knockout cells, ubiquitination assay, proteasome inhibitor rescue, Western blotting\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — identifies E3 ligase for ARC with mutagenesis, KO rescue, and in vivo cardiac model validation\",\n      \"pmids\": [\"17142834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"p53 transcriptionally represses ARC at both the mRNA and protein levels in response to reactive oxygen species and anoxia. p53-induced ARC repression is transcription-dependent. ARC can interact with proapoptotic proteins PUMA and Bad via its N-terminus, displacing their association with Bcl-2. p53-mediated ARC repression prevents ARC from counteracting PUMA/Bad proapoptotic activity.\",\n      \"method\": \"p53 knockdown (siRNA), quantitative RT-PCR, Western blotting, co-immunoprecipitation, domain mapping\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — siRNA knockdown plus Co-IP for binding partners; transcriptional mechanism inferred from mRNA/protein concordance\",\n      \"pmids\": [\"17998337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ARC directly binds the p53 tetramerization domain in the nucleus, inhibiting p53 tetramerization. This exposes a nuclear export signal in p53 and triggers Crm1-dependent relocalization of p53 to the cytoplasm. Knockdown of endogenous ARC in breast cancer cells results in spontaneous p53 tetramerization, nuclear p53 accumulation, and activation of p53 target genes.\",\n      \"method\": \"Co-immunoprecipitation, nuclear/cytoplasmic fractionation, CRM1 inhibitor (leptomycin B), ARC siRNA knockdown, p53 target gene reporter assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (Co-IP, fractionation, pharmacological inhibition, KD) with clear mechanistic chain; single lab but strong evidence\",\n      \"pmids\": [\"18087040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ARC is the only caspase-8 inhibiting regulator with consistently elevated expression across all stages of renal cell carcinomas. The ratio of ARC to caspase-8 mRNA is significantly increased during RCC carcinogenesis and tumor progression, suggesting ARC's inhibition of caspase-8 contributes to RCC chemoresistance.\",\n      \"method\": \"Quantitative RT-PCR in primary human RCC tissues and non-neoplastic renal tissue across tumor stages\",\n      \"journal\": \"Apoptosis : an international journal on programmed cell death\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — expression analysis only, no direct mechanistic experiment\",\n      \"pmids\": [\"18516683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ras induces ARC expression through effects on both transcription and protein stability. Overexpression of activated N-Ras or H-Ras increases ARC mRNA and protein. Ras activates the NOL3 promoter in a MEK/ERK-dependent manner. Ras also stabilizes ARC protein by suppressing its polyubiquitination and proteasomal degradation. ARC mediates Ras-induced cell survival and cell cycle progression.\",\n      \"method\": \"Activated Ras overexpression, N-Ras siRNA knockdown, promoter reporter assay, MEK inhibitor treatment, ubiquitination assay, transgenic mouse model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (promoter assay, KD, OE, MEK inhibitor, in vivo transgenic) in single study establishing full pathway\",\n      \"pmids\": [\"20392691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARC promotes breast carcinogenesis by driving primary tumor growth, invasion, and metastasis, and by conferring chemoresistance. In the PyMT transgenic model, deletion of the ARC-encoding gene nol3 decreased primary tumor burden and markedly reduced lung metastases. Ectopic ARC overexpression in metastatic breast cancer cells increased invasion in vitro and lung metastasis in vivo. RNAi-mediated knockdown of ARC in human MDA-MB-231-LM2 cells reduced tumor volume, local invasion, and lung metastases.\",\n      \"method\": \"ARC knockout in PyMT transgenic mice, ARC overexpression in metastatic cell line, RNAi knockdown in humanized orthotopic model, in vitro invasion assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and gain-of-function in vivo models with defined metastatic phenotype; two independent model systems\",\n      \"pmids\": [\"22037876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A mutation in NOL3 (identified by targeted sequencing and linkage to chromosome 16q21-22.1) cosegregates with familial cortical myoclonus in a 4-generation Canadian Mennonite family. This mutation was found to alter post-translational modification of NOL3 protein in vitro, suggesting altered NOL3 function underlies neuronal membrane hyperexcitability and myoclonus.\",\n      \"method\": \"SNP mapping, microsatellite linkage, targeted massively parallel sequencing, Sanger sequencing, in vitro post-translational modification assay\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — genetic linkage plus in vitro functional assay of PTM alteration; mechanism partially characterized\",\n      \"pmids\": [\"22926851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ARC blocks TNFα-induced regulated necrosis in addition to apoptosis. TNFα-induced necrosis was abrogated by wild-type ARC overexpression but not by a CARD-domain mutant. ARC knockdown exacerbated TNFα-induced necrosis rescued by wild-type but not CARD-defective ARC. The mechanism involves ARC interaction with TNF receptor 1 (TNFR1), interfering with RIP1 recruitment to TNFR1, a critical step in TNFα-induced necrosis.\",\n      \"method\": \"ARC overexpression and siRNA knockdown, CARD domain mutagenesis, co-immunoprecipitation with TNFR1, RIP1 recruitment assay, in vivo vaccinia virus infection model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (OE, KD, CARD mutagenesis, Co-IP of TNFR1-RIP1, in vivo model) converge on novel anti-necrotic mechanism\",\n      \"pmids\": [\"24440909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ARC deficiency in skeletal muscle leads to lower maximum tetanic force, fiber type shift toward type II fibers, reduced fiber cross-sectional area, increased DNA fragmentation, and elevated apoptosis-inducing factor (AIF) in cytosolic fractions. Mitochondria from ARC KO red muscle are more susceptible to calcium stress. These effects occur independent of caspase or calpain activation, indicating caspase-independent mitochondrial apoptotic signaling.\",\n      \"method\": \"ARC knockout mice, muscle contractility measurements, fiber typing, TUNEL assay, subcellular fractionation, AIF Western blot, isolated mitochondrial calcium stress assay\",\n      \"journal\": \"Apoptosis : an international journal on programmed cell death\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple functional and biochemical readouts; mitochondrial mechanism validated ex vivo\",\n      \"pmids\": [\"25596718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Tat-fused NOL3 protein transduces into HT22 hippocampal cells and inhibits H2O2-induced reactive oxygen species production, DNA fragmentation, and mitochondrial membrane potential loss. Tat-NOL3 prevents neuronal cell death by regulating apoptotic signaling including Bax, Bcl-2, caspase-2, -3, -8, PARP, and p53. In a forebrain ischemia model, Tat-NOL3 transduced into brain tissue and protected CA1 hippocampal neurons by regulating microglial and astrocyte activation.\",\n      \"method\": \"TAT-fusion protein transduction, ROS measurement, mitochondrial membrane potential assay, Western blotting of apoptotic markers, in vivo ischemia model with immunohistochemistry\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — TAT-protein delivery with multiple downstream pathway readouts in vitro and in vivo; single lab\",\n      \"pmids\": [\"27221790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ARC regulates leukemia-microenvironment interactions through an ARC/IL1β/Cox-2/PGE2/β-catenin/ARC circuit. AML-MSC cocultures increase Cox-2 expression in MSCs and PGE2 production in an ARC/IL1β-dependent manner. PGE2 induces β-catenin expression in AML cells, which in turn regulates ARC levels. β-catenin inhibition decreases ARC and sensitizes AML cells to chemotherapy. ARC-knockdown AML cells in mice show lower IL1β/PGE2 levels and increased chemosensitivity.\",\n      \"method\": \"AML-MSC co-culture, ARC knockdown, β-catenin inhibition, ELISA for IL1β and PGE2, xenograft mouse model with ARC-knockdown cells\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — circuit validated in co-culture and in vivo xenograft with multiple biochemical readouts; single lab\",\n      \"pmids\": [\"30674535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NOL3/ARC inhibits both intrinsic (mitochondrial) and extrinsic (death receptor) apoptosis pathways, as well as necrosis, through its CARD domain. ARC interacts with Bax, Bcl-2, caspase-2, caspase-8, FADD, Fas, and TNFR1. ARC also modulates ER stress responses, oxidative stress, and Ca2+ homeostasis in cardiomyocytes. CK2-mediated phosphorylation at Thr149 governs ARC's mitochondrial localization and caspase inhibitory function.\",\n      \"method\": \"Review synthesizing co-immunoprecipitation, mutagenesis, knockout mouse data, and in vitro/in vivo functional studies from multiple prior publications\",\n      \"journal\": \"Apoptosis : an international journal on programmed cell death\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — review article synthesizing established mechanistic findings; confidence based on underlying primary studies\",\n      \"pmids\": [\"33604728\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOL3/ARC is a CARD-containing anti-apoptotic protein predominantly expressed in terminally differentiated cells (cardiomyocytes, skeletal muscle, neurons) that inhibits both extrinsic and intrinsic apoptosis pathways and TNFα-induced necrosis through nonhomotypic CARD-domain interactions with Fas/FADD death domains, Bax, caspase-8, and TNFR1/RIP1; its activity is regulated by CK2-mediated phosphorylation at Thr149 (governing mitochondrial targeting and caspase-8 binding), MDM2/Ras-MEK/ERK-controlled ubiquitin-proteasomal degradation, calcium binding via its P/E-rich domain, and nuclear localization in cancer cells where it inactivates p53 by blocking tetramerization and triggering Crm1-dependent nuclear export.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NOL3 (ARC) is a CARD-domain anti-apoptotic protein that suppresses cell death through multiple mechanisms in postmitotic and cancer cells. Its N-terminal CARD domain directly binds caspase-8, TNFR1, and the pro-apoptotic proteins PUMA and Bad—sequestering Bad and PUMA away from Bcl-2 to block intrinsic apoptosis and preventing RIP1 recruitment to TNFR1 to inhibit both extrinsic apoptosis and TNFα-induced necrosis [PMID:17998337, PMID:24440909]. Its C-terminal proline/glutamate-rich domain binds Ca²⁺ to buffer cytosolic calcium transients and is specifically required for neuroprotection against ischemia, while an alternatively spliced nuclear isoform (Nop30) with an SR-rich C-terminus binds splicing factor SRp30c and modulates alternative exon usage [PMID:15509781, PMID:12753927, PMID:10196175]. NOL3 protein levels are controlled by MDM2 RING-finger-dependent ubiquitination/proteasomal degradation (enhanced by p53 and oxidative stress) and by Ras/MEK/ERK-dependent transcriptional induction; in cancer, NOL3 promotes tumor growth, invasion, metastasis, and chemoresistance, while a dominant missense NOL3 mutation that alters post-translational modification underlies familial cortical myoclonus [PMID:17142834, PMID:20392691, PMID:22037876, PMID:22926851].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of two alternatively spliced NOL3 isoforms established that the gene encodes both a cytosolic anti-apoptotic protein and a nuclear/nucleolar isoform (Nop30) that directly binds splicing factor SRp30c and alters alternative exon selection, revealing an unexpected link between a CARD-domain protein and pre-mRNA splicing.\",\n      \"evidence\": \"Yeast two-hybrid, co-immunoprecipitation, subcellular localization, and splicing reporter assays in mammalian cells\",\n      \"pmids\": [\"10196175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Endogenous RNA targets of Nop30-directed splicing regulation are unknown\",\n        \"Whether Nop30 isoform contributes to apoptosis regulation is unresolved\",\n        \"Structural basis of SRp30c-Nop30 interaction not determined\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that ARC is lost in vulnerable CA1 neurons after ischemia and that its C-terminal P/E-rich domain is specifically required for neuroprotection established the first domain-resolved mechanism for NOL3 action in the nervous system, distinct from its CARD-dependent caspase interactions.\",\n      \"evidence\": \"In vivo global ischemia model, hypoxia culture, domain-deletion overexpression constructs, and cell viability assays\",\n      \"pmids\": [\"12753927\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular target(s) of the P/E-rich domain mediating neuroprotection were not identified\",\n        \"Whether CARD-dependent interactions also contribute to neuronal protection was not tested\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that the C-terminal P/E-rich domain directly binds Ca²⁺ and that elevated Ca²⁺ disrupts the ARC–caspase-8 interaction provided a mechanistic link between calcium signaling and apoptotic threshold, explaining how calcium overload could switch ARC from anti-apoptotic to permissive.\",\n      \"evidence\": \"Ca²⁺ overlay assay, Stains-all assay, co-immunoprecipitation under varying Ca²⁺ conditions, and thapsigargin treatment in cells\",\n      \"pmids\": [\"15509781\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Physiological Ca²⁺ concentrations at which the switch occurs in vivo are undefined\",\n        \"Whether calcium binding alters Nop30 isoform function is unknown\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing that MDM2 directly ubiquitinates ARC via its RING finger domain and that oxidative stress upregulates MDM2 to trigger ARC degradation resolved how stress signals converge on ARC protein stability in cardiomyocytes.\",\n      \"evidence\": \"Ubiquitination assays, MDM2 RING-finger C464A mutant, MDM2 knockout fibroblast rescue, proteasomal inhibitor experiments\",\n      \"pmids\": [\"17142834\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific lysine residues on ARC targeted by MDM2 not mapped\",\n        \"Whether other E3 ligases also regulate ARC turnover is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that p53 transcriptionally represses NOL3 and that ARC sequesters PUMA and Bad away from Bcl-2 established a feedforward circuit: p53 removes ARC, releasing pro-apoptotic BH3-only proteins to activate the mitochondrial death pathway.\",\n      \"evidence\": \"p53 knockdown/mRNA and protein quantification, co-immunoprecipitation of ARC with PUMA and Bad, binding domain mapping\",\n      \"pmids\": [\"17998337\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct p53-binding site on the NOL3 promoter not mapped\",\n        \"Stoichiometry of ARC–PUMA/Bad complexes relative to Bcl-2 pools not quantified\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing that Ras/MEK/ERK transcriptionally induces NOL3 and simultaneously stabilizes ARC protein by suppressing polyubiquitination explained how oncogenic Ras co-opts ARC for survival and cell cycle progression in epithelial cancers.\",\n      \"evidence\": \"Ras overexpression/knockdown, NOL3 promoter-reporter assays, ubiquitination assays, transgenic mammary tumor mouse model\",\n      \"pmids\": [\"20392691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific ERK-responsive transcription factor(s) binding the NOL3 promoter not identified\",\n        \"Which deubiquitinase or E3 ligase is modulated by ERK signaling to stabilize ARC is unknown\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Bidirectional gain- and loss-of-function experiments in breast cancer models showed that ARC is necessary and sufficient for tumor invasion and metastasis, extending its role from cell-autonomous survival to tissue-level malignant behavior and chemoresistance.\",\n      \"evidence\": \"NOL3 knockout in PyMT transgenic mice, ectopic overexpression, RNAi, orthotopic xenografts, invasion assays, lung metastasis quantification\",\n      \"pmids\": [\"22037876\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct molecular mechanism by which ARC promotes invasion is unknown\",\n        \"Whether CARD domain or P/E-rich domain is required for pro-metastatic function not dissected\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of a dominant NOL3 missense mutation co-segregating with familial cortical myoclonus, with demonstrated altered post-translational modification, established NOL3 as a Mendelian disease gene and implicated its PTM regulation in neuronal excitability.\",\n      \"evidence\": \"SNP mapping, microsatellite linkage, targeted next-generation sequencing, Sanger sequencing, in vitro PTM assay in a 4-generation family\",\n      \"pmids\": [\"22926851\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-family study; not independently replicated in unrelated kindreds\",\n        \"Which specific PTM is altered and how it affects neuronal function is not resolved\",\n        \"Whether the mutation affects CARD or P/E domain function is unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that ARC inhibits TNFα-induced necrosis through CARD-dependent binding to TNFR1 that blocks RIP1 recruitment extended ARC function beyond apoptosis to regulated necrosis, validated in vivo by exacerbated necrosis in ARC-deficient mice.\",\n      \"evidence\": \"Co-immunoprecipitation with TNFR1, CARD mutant analysis, ARC knockout mouse with vaccinia virus and TNFα-SIRS models\",\n      \"pmids\": [\"24440909\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ARC also affects RIPK3 or MLKL in the necroptotic cascade is untested\",\n        \"Relative contribution of anti-necrotic vs. anti-apoptotic ARC functions in disease settings is undefined\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"ARC knockout mice revealed a role for NOL3 in maintaining slow/oxidative skeletal muscle integrity through suppression of caspase-independent, AIF-mediated mitochondrial apoptotic signaling, broadening ARC function beyond classical caspase pathways.\",\n      \"evidence\": \"ARC knockout mouse, force measurements, fiber-type immunostaining, TUNEL, AIF quantification, isolated mitochondria calcium stress assay\",\n      \"pmids\": [\"25596718\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether ARC directly interacts with AIF or acts upstream is unknown\",\n        \"Single-lab study; skeletal muscle phenotype not replicated independently\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"In AML, ARC drives a paracrine IL-1β/Cox-2/PGE2/β-catenin feedforward loop between leukemia cells and mesenchymal stroma that sustains ARC expression and confers chemoresistance, revealing a non-cell-autonomous pro-survival circuit.\",\n      \"evidence\": \"AML-MSC co-culture, Cox-2/PGE2 measurement, β-catenin inhibition, ARC knockdown, NOD/SCID xenograft model\",\n      \"pmids\": [\"30674535\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct mechanism by which ARC promotes IL-1β release is unknown\",\n        \"Whether this paracrine loop operates in solid tumors expressing ARC is untested\",\n        \"β-catenin binding site on the NOL3 promoter not mapped\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of CARD-mediated interactions with its diverse partners (caspase-8, TNFR1, PUMA, Bad), the identity of the specific PTM altered by the cortical myoclonus mutation and its neuronal consequence, the mechanism by which ARC promotes cell invasion/metastasis, and endogenous RNA targets of the nuclear Nop30 isoform.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural data for ARC or its complexes\",\n        \"PTM identity altered in familial cortical myoclonus unknown\",\n        \"Mechanism of ARC-driven invasion/metastasis undefined\",\n        \"Nop30 endogenous splicing targets not catalogued\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 3, 4, 9]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 6]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [7, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 3, 4, 7, 9, 11]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5, 10]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 8, 10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CASP8\",\n      \"MDM2\",\n      \"TNFRSF1A\",\n      \"BBC3\",\n      \"BAD\",\n      \"SRSF1\",\n      \"TP53\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"NOL3 (ARC) is a CARD-domain-containing inhibitor of programmed cell death that protects terminally differentiated cells—particularly cardiomyocytes, skeletal myocytes, and neurons—from apoptotic and necrotic stimuli. Its N-terminal CARD engages in nonhomotypic interactions with the death domains of Fas, FADD, TNFR1, and the pro-apoptotic effector Bax, thereby blocking both extrinsic DISC assembly and intrinsic mitochondrial cytochrome c release, as well as TNFα-induced necrosis by preventing RIP1 recruitment to TNFR1 [PMID:15383280, PMID:24440909]. CK2-mediated phosphorylation at Thr149 targets ARC to mitochondria and is required for caspase-8 binding, while MDM2-dependent ubiquitin-proteasomal degradation and Ras-MEK/ERK-driven transcriptional and post-translational stabilization set its steady-state levels [PMID:12191471, PMID:17142834, PMID:20392691]. In cancer cells ARC accumulates in the nucleus where it binds the p53 tetramerization domain, triggering Crm1-dependent p53 nuclear export and functional inactivation, promoting tumor growth, chemoresistance, and metastasis [PMID:18087040, PMID:22037876].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of ARC as a tissue-restricted, CARD-containing caspase inhibitor established that a dedicated anti-apoptotic protein exists in skeletal and cardiac muscle to block death-receptor signaling.\",\n      \"evidence\": \"Co-immunoprecipitation and caspase activity assays in 293T cells with death receptor stimulation\",\n      \"pmids\": [\"9560245\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous loss-of-function not yet tested\", \"Mechanism of selective caspase recognition unknown\", \"Intrinsic pathway role not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery of alternative splicing producing a nuclear/nucleolar Nop30 isoform that modulates pre-mRNA splicing revealed that NOL3 has functions beyond apoptosis inhibition.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP with splicing factor SRp30c, and alternative splicing reporter assays\",\n      \"pmids\": [\"10196175\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of Nop30-mediated splicing regulation not established in vivo\", \"Relationship between nucleolar and cytoplasmic isoform functions unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstration that CK2 phosphorylation at Thr149 directs ARC to mitochondria and is required for caspase-8 binding resolved how a cytoplasmic protein gains access to its target.\",\n      \"evidence\": \"In vitro kinase assay, T149A mutagenesis, subcellular fractionation, and Co-IP\",\n      \"pmids\": [\"12191471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling CK2-ARC axis not defined\", \"Whether dephosphorylation reverses mitochondrial targeting unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapping of ARC's nonhomotypic CARD interactions with Fas/FADD death domains and Bax C-terminus unified its roles in extrinsic and intrinsic apoptosis under a single structural mechanism.\",\n      \"evidence\": \"Reciprocal Co-IP, DISC assembly assays, Bax activation/translocation assays, siRNA knockdown and overexpression\",\n      \"pmids\": [\"15383280\", \"15004034\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure of CARD-DD or CARD-Bax complexes\", \"Stoichiometry and competition between targets unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of ARC as a calcium-binding protein whose P/E-rich domain binds Ca²⁺ and modulates caspase-8 interaction linked calcium homeostasis to death-pathway regulation.\",\n      \"evidence\": \"Ca²⁺ overlay assay, Stains-all, Co-IP under varying Ca²⁺, thapsigargin treatment\",\n      \"pmids\": [\"15509781\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ca²⁺ binding affinity and kinetics not quantified\", \"Structural basis for Ca²⁺-regulated interaction unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"ARC knockout mice revealed that endogenous ARC is dispensable for development but essential for cardioprotection under ischemic and biomechanical stress, validating the in vitro anti-apoptotic function in vivo.\",\n      \"evidence\": \"ARC-null mice subjected to aortic banding and ischemia/reperfusion, plus human failing heart tissue analysis\",\n      \"pmids\": [\"16505176\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Neuronal phenotypes in ARC-null mice not characterized\", \"Redundancy with other anti-apoptotic CARD proteins not explored\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that MDM2 ubiquitinates ARC for proteasomal degradation, and that ubiquitin-site mutants stabilize ARC and enhance cytoprotection, established post-translational turnover as a key regulatory axis.\",\n      \"evidence\": \"Pulse-chase, ubiquitin acceptor mutagenesis, MDM2 RING mutant, MDM2-null cell rescue\",\n      \"pmids\": [\"17142452\", \"17142834\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Additional E3 ligases not excluded\", \"Deubiquitinase for ARC not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Finding that nuclear ARC binds the p53 tetramerization domain and triggers Crm1-dependent p53 export revealed a pro-oncogenic function distinct from its canonical anti-apoptotic role.\",\n      \"evidence\": \"Co-IP, nuclear/cytoplasmic fractionation, leptomycin B treatment, ARC siRNA in breast cancer cells\",\n      \"pmids\": [\"18087040\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ARC gains nuclear entry in cancer cells not resolved\", \"Structural interface between ARC CARD and p53 tetramerization domain unmapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstration that Ras-MEK/ERK signaling transcriptionally and post-translationally upregulates ARC connected oncogenic signaling to ARC-mediated survival and cell-cycle progression.\",\n      \"evidence\": \"Activated Ras overexpression, MEK inhibitor, promoter reporter, ubiquitination assay, transgenic mouse\",\n      \"pmids\": [\"20392691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcription factor binding NOL3 promoter not identified\", \"Whether other oncogenic pathways converge on ARC unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of a NOL3 mutation cosegregating with familial cortical myoclonus linked ARC dysfunction to a Mendelian neurological disorder, extending its physiological relevance beyond the heart.\",\n      \"evidence\": \"Linkage mapping, targeted sequencing, Sanger validation, in vitro PTM assay in a 4-generation family\",\n      \"pmids\": [\"22926851\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Precise functional consequence of the mutation on ARC activity in neurons not defined\", \"No animal model recapitulating the myoclonus phenotype\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Proof that ARC blocks TNFα-induced necrosis via its CARD domain by disrupting RIP1 recruitment to TNFR1 expanded its role from an apoptosis inhibitor to a general cell death suppressor.\",\n      \"evidence\": \"ARC overexpression/knockdown, CARD mutagenesis, TNFR1-RIP1 Co-IP, in vivo vaccinia virus model\",\n      \"pmids\": [\"24440909\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ARC modulates MLKL-dependent necroptosis downstream of RIPK3 not tested\", \"Relative contribution of anti-necrotic vs anti-apoptotic activity in vivo unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Characterization of ARC-null skeletal muscle revealed caspase-independent, AIF-mediated apoptosis and mitochondrial calcium vulnerability, showing ARC protects against non-canonical apoptotic pathways.\",\n      \"evidence\": \"ARC knockout mice, muscle contractility, TUNEL, subcellular fractionation for AIF, isolated mitochondrial calcium stress\",\n      \"pmids\": [\"25596718\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ARC-AIF interaction not demonstrated\", \"Whether fiber-type shift is cell-autonomous not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Structural basis of ARC's nonhomotypic CARD interactions with death domains, Bax, and p53, the mechanism of its nuclear import in cancer cells, and the identity of transcription factors directly driving NOL3 expression downstream of Ras-ERK remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of ARC or its complexes\", \"Nuclear import signal or carrier for ARC in cancer not identified\", \"Transcription factor occupancy at NOL3 promoter not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 5, 6, 18]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [5, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2, 6, 19]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 13]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 5, 6, 9, 18, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [15, 21]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CASP8\", \"BAX\", \"FAS\", \"FADD\", \"TNFR1\", \"TP53\", \"MDM2\", \"RIPK1\"],\n    \"other_free_text\": []\n  }\n}\n```"}